ES2054633T3 - Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas. - Google Patents

Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas.

Info

Publication number
ES2054633T3
ES2054633T3 ES87110551T ES87110551T ES2054633T3 ES 2054633 T3 ES2054633 T3 ES 2054633T3 ES 87110551 T ES87110551 T ES 87110551T ES 87110551 T ES87110551 T ES 87110551T ES 2054633 T3 ES2054633 T3 ES 2054633T3
Authority
ES
Spain
Prior art keywords
probucol
heart disease
prevention
treatment
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87110551T
Other languages
English (en)
Inventor
Aloys Dr Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2054633T3 publication Critical patent/ES2054633T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL UOS DEL PROBUCOL PARA PREVENIR Y TRATAR ENFERMEDADES DEL CORAZON, DONDE ES DESEABLE O NECESARIO UN CONSUMO REDUCIDO DE OXIGENO POR EL MIOCARDIO, TAL COMO CARDIOMIOPATIA DE VARIOS ORIGENES, EL SINDROME DE CORAZON HIPERCINETICO, Y LA ENFERMEDAD DEL CORAZON CORONARIA, INCLUYENDO INSUFICIENCIA CORONARIA Y SUS CONCOMITANTES SINTOMAS DE ENFERMEDADES SECUNDARIAS.
ES87110551T 1986-07-25 1987-07-21 Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas. Expired - Lifetime ES2054633T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863625279 DE3625279A1 (de) 1986-07-25 1986-07-25 Verwendung von probucol zur vorbeugung und behandlung von erkrankungen des herzens

Publications (1)

Publication Number Publication Date
ES2054633T3 true ES2054633T3 (es) 1994-08-16

Family

ID=6306020

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87110551T Expired - Lifetime ES2054633T3 (es) 1986-07-25 1987-07-21 Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas.

Country Status (5)

Country Link
EP (1) EP0254272B1 (es)
JP (1) JPS63107915A (es)
AT (1) ATE104142T1 (es)
DE (2) DE3625279A1 (es)
ES (1) ES2054633T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214887B1 (en) 1997-03-24 2001-04-10 Quatro Scientific, Inc. Vascular remodeling agent
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
EA010183B1 (ru) 1997-05-14 2008-06-30 Атеродженикс, Инк. Сложный моноэфир янтарной кислоты и пробукола для лечения сердечно-сосудистых и воспалительных заболеваний
AU2001253401B2 (en) 2000-04-11 2006-12-07 Atherogenics, Inc Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
AU2008230861A1 (en) 2007-03-26 2008-10-02 Salutria Pharmaceuticals, Llc Methods and compositions of derivatives of probucol for the treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US960003A (en) * 1909-09-11 1910-05-31 Alexander F Divok Folding steps.
DE3530256A1 (de) * 1985-08-23 1987-02-26 Merrell Dow Pharma Verwendung von probucol bei der behandlung von herzarrhythmie

Also Published As

Publication number Publication date
EP0254272B1 (en) 1994-04-13
DE3625279A1 (de) 1988-02-04
EP0254272A3 (en) 1989-11-23
DE3789579D1 (de) 1994-05-19
DE3789579T2 (de) 1994-10-13
ATE104142T1 (de) 1994-04-15
EP0254272A2 (en) 1988-01-27
JPS63107915A (ja) 1988-05-12

Similar Documents

Publication Publication Date Title
ES2186670T3 (es) Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
ES2058423T3 (es) Composicion de factor de crecimiento de fibroblastos, resistente a los acidos, para tratar enfermedades ulcerantes del tracto gastrointestinal.
ATE113208T1 (de) Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen.
ATE228004T1 (de) Verwendung von relaxin zur stimulierung der angiogenese
FI875544A0 (fi) Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
ATE256736T1 (de) Ein nicht-mitogener kompetitiver hgf-antagonist
ES2054633T3 (es) Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2061447T3 (es) Compuestos con efecto nootropo, agentes que los contienen y su empleo en el tratamiento y la profilaxis de disfunciones cognitivas.
ES2051710T3 (es) Utilizacion de d-fenfluramina para la fabricacion de medicamentos para el tratamiento de depresiones.
ES2064328T3 (es) Indolilpropanoles, procedimiento para su fabricacion y su uso, asi como preparaciones que contienen los compuestos.
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
FI890342A0 (fi) Hjaernmitogener, som binds till heparin.
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
ES2064375T3 (es) Factor del estres humano por calor.
ES2058349T3 (es) Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.
NO890681D0 (no) Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner.
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254272

Country of ref document: ES